Loading...
OTCM
KBLB
Market cap117mUSD
Jul 09, Last price  
0.11USD
1D
-0.77%
1Q
-23.31%
Jan 2017
97.25%
IPO
111.06%
Name

Kraig Biocraft Laboratories Inc

Chart & Performance

D1W1MN
OTCM:KBLB chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
4.54%
Rev. gr., 5y
137.13%
Revenues
0k
000000000031,85897,318401,6200000000
Net income
-4m
L+6.60%
-530,000-473,000-360,104-1,432,000-1,783,000-1,295,000-1,202,921-7,468,000-1,873,000-2,134,000-3,074,000-2,333,000-1,169,000-3,204,000-5,358,000-8,046,000-3,842,000-3,030,000-3,399,000-3,623,353
CFO
-2m
L-2.73%
-10,010-411,067-96,281-132,967-195,450-556,096-562,922-800,154-904,559-967,563-1,011,841-729,542-235,005-1,087,881-1,254,712-1,800,809-1,887,187-1,244,483-1,839,086-1,788,970

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. The company’s products are used in performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, and other applications; military and police for its ballistic protection; and geotextiles, safe and protective clothing, textiles used in transportation and buildings, and functional and sportive textiles. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.
IPO date
Feb 29, 2008
Employees
36
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT